English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFor the study, which involved patients from across the world, Yale Cancer Center (YCC) researchers at Yale School of Medicine (YSM) analyzed the genetic landscape of 66 tumors, the largest series of cervical NET ever reported in scientific literature.
Tag: Cervical Cancer
Researchers Identify New Genetic Risk Factors for Persistent HPV Infections
Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.
Researchers Identify New Genetic Risk Factors for Persistent HPV Infections
Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.
A bioengineering professor finds her niche in global health
In honor of International Women’s Day, we’re featuring Rebecca Richards-Kortum, Ph.D., a professor of bioengineering at Rice University who has been solving women’s health challenges globally for the past two decades.
New B.C. Self-Screening Program Will Improve Accessibility of Cervical Cancer Testing
The launch of British Columbia’s province-wide program offering the first-ever option to self-screen for HPV in Canada will enhance access to cervical cancer screening for women and individuals with a cervix. Offering a more convenient, accessible way to screen for…
The Foundation for Women’s Cancer to Host Free Patient and Advocates Education Forum in San Diego
The Foundation for Women’s Cancer (FWC) is pleased to host a free Patient and Advocate Education Forum on Friday, March 15, 2024, 10 a.m. – 4:30 p.m. PT, in San Diego, CA, at the San Diego Convention Center. The organization welcomes all gynecologic cancer (cervical, endometrial/uterine, ovarian, vaginal, and vulvar) patients, advocates, family members, and providers.
New Study Shows Insurance Coverage Disruptions Affect Key Cancer Screenings for U.S. Adults
A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.
Mount Sinai Receives $4.6 Million From The Pershing Square Foundation to Support Women’s Health Research and Careers for Women in Science
The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from The Pershing Square Foundation to support women’s health research and advance careers for female scientists
Better use of existing drugs increases cervical cancer survival and reduces recurrence
A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.
Sexual activity and vaginal dilation associated with fewer side effects after cervical cancer treatment
People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer are at lower risk for long-term side effects, according to a new study from researchers in Austria.
Liquid biopsies can rapidly detect residual disease following cervical chemoradiation, study finds
Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after the completion of chemoradiation, a new study confirms.
New Test Shows Promise for Detecting Hard-to-Find Cervical Cancers
In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss. The findings published online today in the Journal of the National Cancer Institute (JNCI).
New Research Shows Promising Possibilities for At-Home Testing to Detect Sexually Transmitted Infections
Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research presented today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.
Study supports “catch up” HPV test in older women
For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a “catch up” HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as compared to women not offered screening.
New Study Shows Mortality Rates for All Major Cancers Decreasing Globally, Except Liver Cancer in Men and Lung Cancer in Women
A new study conducted by scientists at the American Cancer Society and Brookdale University Hospital Medical Center reveals recent mortality rates for all major cancers decreased in most of the studied countries except lung cancer in females and liver cancer in males, where increasing rates were observed in most countries. The research also showed that cancer-specific mortality rates varied substantially across countries, with rates of lung and cervical cancer varying by 10-fold. The study was published today in the journal Cancer Epidemiology, Biomarkers & Prevention, a publication of the American Association for Cancer Research.
HPV Self-Collection Kits Increase Screening Among Under-screened, Under-served Women in North Carolina
Five years ago, the World Health Organization (WHO) announced a global call to eliminate cervical cancer. Because nearly all cervical cancers are caused by an initial infection with oncogenic types of human papillomavirus (HPV), screening for the virus is critical to preventing and treating the disease.However, providing HPV screening only within clinical settings may limit access to screening for many under-served women across the United States and here, in North Carolina.
The Foundation for Women’s Cancer to Host Patient and Advocates Education Forum at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer in Tampa on March 24
The Foundation for Women’s Cancer will host a Patients and Advocates Education Forum and Luncheon on Friday, March 24, 2023 in Tampa, FL during the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.
New Smoking Cessation Intervention Helps Patients with Cervical Cancer Precursor or Cervical Cancer Quit Smoking
In a new study published in the Journal of Clinical Oncology, Moffitt Cancer Center researchers report that a new smoking cessation intervention increased the number of patients who quit smoking compared to standard cessation approaches.
New AACC Guidance Aims to Serve as a Roadmap for Healthcare Professionals Navigating Cervical Cancer Testing Options
With the goal of improving cervical cancer care, AACC has published a new guidance document with expert recommendations on detecting this cancer. The guidance aims to update healthcare and laboratory medicine professionals on the latest advancements in this field, and to help them select the most effective cervical cancer detection strategy for their patients.
De Casa en Casa program reducing the burden of cervical cancer by facilitating early diagnosis and access to treatment.
Regular pap tests and HPV testing can prevent and often catch cases of cervical cancer. Each year, approximately 13,000 women are diagnosed with cervical cancer and about 4,000 women die from cervical cancer in the US. Sixty percent of cervical…
American Cancer Society Releases Latest Cancer Statistics, Launches Initiative to Address Prostate Cancer Resurgence and Disparities
Today, the American Cancer Society released Cancer Statistics, 2023, the organization’s annual report on cancer facts and trends. According to the report, overall cancer mortality has dropped 33% since 1991, averting an estimated 3.8 million cancer deaths. Based on ACS data, in 2023 there are projected to be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States.
MD Anderson Research Highlights for January 11, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
What’s the Connection Between HPV and Cervical Cancer? And More Questions You’re Reluctant to Ask
Cervical cancer is often stigmatized due to its association with human papilloma virus (HPV), a sexually transmitted infection, however, HPV is extremely common, affecting most adults. Some people may also feel uncomfortable asking their doctor about sexual health .James K. Aikins, Jr., MD, FACOG, FACS, chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey, answers questions about HPV, cervical cancer and more.
New drug combination offers hope for improved treatment of cervical cancer
A new combination of drugs slowed the growth of cancer cells by an unexpected mechanism that may one day lead to improved treatment of cervical cancer, a UT Southwestern-led study published in Molecular Cancer Research suggests.
Are older women being over-screened for cervical cancer?
Analysis showed that in 2019 more than 1.3 million women received cervical cancer screening-associated services, such as a Pap test, colposcopy and other cervical procedures, after age 65. While these services cost more than $83 million, the researchers concluded they were of “unclear clinical appropriateness.”
Researchers Receive $3.2 Million to Study Efficacy of Mind-body Practices in Improving Pain, Surgical Outcomes
Can mind-body practices such as gentle yoga or self-reflection benefit patients undergoing surgery? It’s a question that researchers at Wake Forest University School of Medicine are examining with the support of a five-year, $3.2 million grant from the National Cancer Institute (NCI).
Sexual side effects of cancer treatment often unaddressed with female patients
A new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients than with male patients, even when the treatment directly affects sex organs.
UTHealth Houston study: Lower cancer screening rates differ by region, tied to social vulnerability
Populations in U.S. counties defined as more vulnerable based on social factors including socioeconomic status and racial/ethnic minority status were significantly less likely to receive timely breast, cervical, and colorectal cancer screenings, according to research from UTHealth Houston.
Molecular Musical Chairs
The human papillomavirus (HPV) vaccine is safe and effective – but it’s not for everyone. Michelle Ozbun, PhD, and her team at UNM Cancer Center published a research article earlier this year in Antimicrobial Agents and Chemotherapy in which they describe how a drug called protamine sulfate blocks HPV infection. Like a game of musical chairs among molecules, the drug molecules bind to heparan sulfate cell receptors, preventing HPV virus particles from doing so.
Steepest annual rise in advanced cervical cancer in US among White women
The steepest annual rise in new cases of advanced womb (cervical) cancer in the US is among White women, who are significantly less likely to have the preventive HPV (human papillomavirus) jab or to be screened for the disease, finds research published online in the International Journal of Gynecological Cancer.
Study Reveals Cancer Screening Decreased Worldwide During Height of Pandemic
A study that surveyed cancer screening data included in medical journals worldwide from January 2020 into December 2021 showed significant decreases in the number of screenings for breast, colorectal and cervical cancers during the early phase of the Covid-19 pandemic.
Study Finds COVID-19 Pandemic Reduced Breast, Cervical, Colorectal Cancer Screenings by Millions in 2020
New findings led by researchers at the American Cancer Society show the number of women in the United States who reported having a recent (in the past year) breast cancer or cervical cancer screening dropped by 2.13 million (6%) and 4.47 million (11%) respectively in 2020 compared to 2018. The study is the first of its kind to evaluate the impact of the COVID-19 pandemic on cancer screenings nationally using population-based data.
Cervical cancer screening happens less often among sexual minority individuals
A recent database analysis reveals that in recent years, sexual minority individuals—those whose sexual orientation differs from societal norms—were less likely to have undergone cervical cancer screening tests than heterosexual counterparts, with Hispanic sexual minority individuals having the lowest screening rates.
Targeting Cervical Cancer Stem Cells to Improve Outcomes
The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.
Minimally Invasive Approach to Hysterectomy in Cervical Cancer Associated with Poorer Disease-Free Survival Than Open Surgery
Minimally invasive surgery was associated with lower survival rates than open surgery as a treatment for cervical cancer, according to the final analysis of data from the LACC trial.
NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
International collaboration involving NCCN and Polish oncology officials publishes first of several evidence-based expert consensus guidelines with latest cancer treatment recommendations, adapted for regional needs, beginning with cervical cancer.
Women’s Wellness: Types of Gynecologic Cancers and their Warning Signs
September is Gynecologic Cancer Awareness Month. Rutgers Cancer institute of New Jersey Gynecologic Oncology Chief Dr. James Aikins reminds women about the types of gynecologic cancers and their warning signs
CAP Foundation Announces $2M Fundraising Campaign Supporting Cancer Screening, Pathology
The College of American Pathologists (CAP) Foundation announced in July 2021 a new fundraising campaign with a minimum goal of $2 million that will secure life-saving cancer screening and pathology education and training programs for the next decade.
American Society for Colposcopy and Cervical Pathology discusses updated American Cancer Society guidelines on cervical cancer screening
Last year, the American Cancer Society (ACS) issued an updated set of guidelines for cervical cancer screening – emphasizing the shift toward screening with primary human papillomavirus (HPV) testing. While the ACS recommendation accounts for a transition period to implement primary HPV screening, additional factors should be considered to operationalize these guidelines, according to a special white paper in the July issue of the Journal of Lower Genital Tract Disease (JLGTD), official journal of ASCCP. The journal is published in the Lippincott portfolio by Wolters Kluwer.
MD Anderson Research Highlights for June 30, 2021
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include expanded use of a targeted therapy for a new group of patients with leukemia, molecular studies yielding novel cancer therapeutic targets, insights into radiation therapy resistance and a community intervention to reduce cervical cancer rates.
Sanford Burnham Prebys and other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
Sanford Burnham Prebys has joined doctors & scientists across America at National Cancer Institute (NCI)-designated cancer centers & other organizations to issue a joint statement urging the nation’s physicians, parents & young adults to get the human papillomavirus (HPV) vaccination back on track.
New article examines impact of a randomized trial on the use of minimally invasive surgery for cervical cancer
In a Correspondence to the New England Journal of Medicine, researchers found that many medical centers changed surgical practices for early cervical cancer based on findings from the LACC study in 2018, but non-academic medical centers could improve in making the change compared with academic centers.
Cervical Cancer Testing Tech Could Replace Pap Smears, Save Lives
Emerging technologies can screen for cervical cancer better than Pap smears and, if widely used, could save lives in areas where access to health care may be limited. In Biophysics Reviews, scientists at Massachusetts General Hospital write advances in nanotechnology and computer learning are among the technologies helping develop HPV screening that take the guesswork out of the precancer tests. That could mean better screening in places that lack highly trained doctors and advanced laboratories.
A World without Cervical Cancer: Preventive Medicine publishes special issue to further global efforts to eliminate deadly disease
Cervical cancer is a serious global health threat which kills more than 300,000 women every year. Recognizing this urgent public health issue, the editorial team of Preventive Medicine is publishing a special issue titled “From Science to Action to Impact: Eliminating Cervical Cancer,” which outlines the required courses of action to eliminate cervical cancer. Dr. Anna Giuliano and Dr. Linda Niccolai, two giants in the field of cervical cancer prevention research, served as guest editors for the issue.
A Measure of Cleanliness
Michelle Ozbun, PhD, and her team developed a way to measure how many infectious human papillomavirus particles are left on a surface after it has been disinfected. They found that disinfectants approved for use on medical devices work well, and they recently published their work online in The Lancet journal EBioMedicine.
Cancer cases are rising in adolescents and young adults
Cancer cases in adolescents and young adults have risen by 30% during the last four decades, with kidney cancer rising at the greatest rate, according to researchers at Penn State College of Medicine.
Adding image guidance to post-operative radiation therapy can reduce side effects for women with cervical cancer
A phase III trial from India shows that an advanced radiation therapy technique leads to fewer gastrointestinal side effects in women who receive radiation after undergoing hysterectomy for cervical cancer. Findings from the PARCER trial (NCT01279135) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Research News Tip Sheet: Story Ideas From Johns Hopkins Medicine
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.
What Every Woman Should Know About Preventing Gynecologic Cancers
The best defense against gynecologic cancer starts with preventative measures. When cancer is detected early, there is a better chance of having more effective treatment and better outcomes. While there is not a single screening test for all gynecologic cancers, learn about the ones that do exist.
HPV Vaccinations During Global Pandemic
Human papillomavirus (HPV) is the most common sexually transmitted infection and the cause of most cervical cancers, and some vaginal, penile, anal and oral cancers. The HPV vaccine has proven effective in preventing infection and six types of HPV-attributable cancers. …